1
|
Sanito RC, Mujiyanti DR, You SJ, Wang YF. A review on medical waste treatment in COVID-19 pandemics: Technologies, managements and future strategies. JOURNAL OF THE AIR & WASTE MANAGEMENT ASSOCIATION (1995) 2024; 74:72-99. [PMID: 37955449 DOI: 10.1080/10962247.2023.2282011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/24/2023] [Accepted: 10/23/2023] [Indexed: 11/14/2023]
Abstract
Since the outbreak of COVID-19 few years ago, the increasing of the number of medical waste has become a huge issue because of their harmful impact to environment. A major concern associated to the limitation of technologies for dealing with medical waste, especially conventional technologies, are overcapacities since pandemic occurs. Moreover, the outbreak of new viruses from post COVID-19 should become a serious attention to be prevented not only environmental issues but also the spreading of viruses to new pandemic near the future. The high possibility of an outbreak of new viruses and mutation near the future should be prevented based on the experience associated with the SARS-CoV-2 virus in the last 3 yr. This review presented information and strategies for handling medical waste during the outbreak of COVID-19 and post-COVID-19, and also information on the current issues related to technologies, such as incineration, pyrolysis/gasification, autoclaves and microwave treatment for the dealing with high numbers of medical waste in COVID-19 to prevent the transmission of SARS-CoV-2 virus, their advantages and disadvantages. Plasma technology can be considered to be implemented as an alternative technology to deal with medical waste since incinerator is usually over capacities during the pandemic situation. Proper treatment of specific medical waste in pandemics, namely face masks, vaccine vials, syringes, and dead bodies, are necessary because those medical wastes are mediums for transmission of the SARS-CoV-2 virus. Furthermore, emission controls from incinerator and plasma are necessary to be implemented to reduce the high concentration of CO2, NOx, and VOCs during the treatment. Finally, future strategies of medical waste treatment in the perspective of potential outbreak pandemic from new mutation viruses are discussed in this review paper.Implications: Journal of the air and waste management association may consider our review paper to be published. In this review, we give important information related to the technologies, managements and strategies for handling the medical waste and control the transmission of SARS-CoV-2 virus, starting from proper technology to control the high number of medical waste, their pollutants and many strategies for controlling the spreading of SARS-CoV-2 virus. Moreover, this review also describes some strategies associated with control the transmission not only the SARS-CoV-2 virus but also the outbreak of new viruses near the future.
Collapse
Affiliation(s)
- Raynard Christianson Sanito
- Surface Engineering Laboratory, Advanced Materials Research Center, Department of Mineral, Metallurgical and Materials Engineering, Laval University, Pavillon Adrien-Pouliot, Quebec City, Quebec, Canada
- CHU de Quebec, Hospital Saint-François d'Assise, Laval University, Quebec City, Quebec, Canada
| | - Dwi Rasy Mujiyanti
- Department of Environmental Engineering, Chung Yuan Christian University, Taoyuan, Taiwan
- Department of Civil Engineering, Chung Yuan Christian University, Taoyuan, Taiwan
- Department of Chemistry, Faculty of Mathematics and Natural Sciences, Lambung Mangkurat University, Banjarmasin, Indonesia
| | - Sheng-Jie You
- Department of Environmental Engineering, Chung Yuan Christian University, Taoyuan, Taiwan
- Center for Environmental Risk Management, Chung Yuan Christian University, Taoyuan, Taiwan
| | - Ya-Fen Wang
- Department of Environmental Engineering, Chung Yuan Christian University, Taoyuan, Taiwan
- Center for Environmental Risk Management, Chung Yuan Christian University, Taoyuan, Taiwan
| |
Collapse
|
2
|
Algaissi A, Khan E, Tabassum H, Samreen S, Khamjan NA, Lohani M, Khan S, Kameli N, Madkhali F, Ahmad IZ. Campesterol and dithymoquinone as a potent inhibitors of SARS cov-2 main proteases-promising drug candidates for targeting its novel variants. J Biomol Struct Dyn 2024:1-15. [PMID: 38288958 DOI: 10.1080/07391102.2023.2301684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2023] [Accepted: 09/13/2023] [Indexed: 02/16/2024]
Abstract
The sudden outbreak of the COVID-19 pandemic has currently taken approximately 2.4 million lives, with no specific medication and fast-tracked tested vaccines for prevention. These vaccines have their own adverse effects, which have severely affected the global healthcare system. The discovery of the main protease structure of coronavirus (Mpro/Clpro) has resulted in the identification of compounds having antiviral potential, especially from the herbal system. In this study, the computer-associated drug design tools were utilised to analyze the reported phytoconstituents of Nigella sativa for their antiviral activity against the main protease. Fifty-eight compounds were subjected to pharmacological parameter analysis to determine their lead likeness in comparison to the standard drugs (chloroquine and nirmatrelvir) used in the treatment of SARS-CoV-2. Nearly 31 compounds were docked against five different SARS-CoV-2 main proteases, and all compounds showed better binding affinity and inhibition constant against the proteases. However, dithymoquinone and campesterol displayed the best binding scores and hence were further subjected to dynamics and MMPBSA study for 100 ns. The stability analysis shows that dithymoquinone and campesterol show less variation in fluctuation in residues compared to standard complexes. Moreover, dithymoquinone exhibited higher binding affinity and favorable interaction followed by campesterol as compared to the standard drug. The in silico computational analysis provides a promising hit for regulating the main proteases activity.Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
- Abdullah Algaissi
- Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia
- Emerging and Epidemic Infectious Diseases Research Unit, Medical Research Center, Jazan University, Jazan, Saudi Arabia
| | - Elhan Khan
- Natural Products Laboratory, Department of Bioengineering, Integral University, Lucknow, Uttar Pradesh, India
| | - Heena Tabassum
- Dr. D. Y. Patil Biotechnology and Bioinformatics Institute, Dr. D. Y. Patil Vidyapeeth, Pune, Maharashtra, India
| | - Sadiyah Samreen
- Natural Products Laboratory, Department of Bioengineering, Integral University, Lucknow, Uttar Pradesh, India
| | - Nizar A Khamjan
- Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia
| | - Mohtashim Lohani
- Medical Research Centre, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia
| | - Saif Khan
- Department of Basic Dental and Medical Sciences, College of Dentistry, Ha'il University, Ha'il, Saudi Arabia
| | - Nader Kameli
- Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia
| | - Faisal Madkhali
- Department of Medical Laboratories Technology, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia
| | - Iffat Zareen Ahmad
- Natural Products Laboratory, Department of Bioengineering, Integral University, Lucknow, Uttar Pradesh, India
| |
Collapse
|
3
|
Gully BJ, Padovano HT, Clark SE, Muro GJ, Monnig MA. Exposure to the Death of Others during the COVID-19 Pandemic: Growing Mistrust in Medical Institutions as a Result of Personal Loss. Behav Sci (Basel) 2023; 13:999. [PMID: 38131855 PMCID: PMC10741189 DOI: 10.3390/bs13120999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2023] [Revised: 11/28/2023] [Accepted: 12/05/2023] [Indexed: 12/23/2023] Open
Abstract
BACKGROUND AND AIMS The prominence of death during the COVID-19 pandemic was heightened by the potential of personally knowing someone who lost their life to the virus. The terror management theory (TMT) suggests that the salient presence of death has a pronounced effect on behavior and may result in the ossification of beliefs and actions aligned with one's worldview (i.e., the mortality salience hypothesis). In this study, we evaluated how death exposure early in the COVID-19 pandemic could enact the process of firming up held beliefs and attitudes related to health and safety. Specifically, we tested the hypothesis that exposure to a personal loss during the pandemic would strengthen participants' baseline attitudes and behaviors regarding COVID-19 safety guidelines. METHOD Data were analyzed from a prospective, regional survey administered at two time points during the pandemic, June-July 2020 and May 2021, in five United States northeastern states. Baseline and follow-up surveys were administered approximately 12 months apart, with adherence to public guidance and death exposure measured at both timepoints and other safety measures at follow-up only. FINDINGS Our results indicated that there were significant main effects of death exposure on guideline adherence and support for COVID-related public policy. Contrary to the mortality salience hypothesis, death exposures after baseline were related to higher medical mistrust at follow-up for those high in adherence at baseline, rather than those with low adherence. CONCLUSION Our results offer some conflicting evidence to the mortality salience hypothesis. Rather than entrench people in their worldviews, death in the context of the COVID-19 pandemic appeared to sway people away from their initial stances. This finding has important implications for TMT literature and for the COVID-19 pandemic response.
Collapse
Affiliation(s)
- Brian J. Gully
- Department of Behavioral and Social Sciences, Center for Alcohol and Addiction Studies, Brown University, Providence, RI 02903, USA; (H.T.P.); (S.E.C.); (G.J.M.); (M.A.M.)
- Center for Addiction and Disease Risk Exacerbation, Brown University, Providence, RI 02903, USA
| | - Hayley Treloar Padovano
- Department of Behavioral and Social Sciences, Center for Alcohol and Addiction Studies, Brown University, Providence, RI 02903, USA; (H.T.P.); (S.E.C.); (G.J.M.); (M.A.M.)
- Center for Addiction and Disease Risk Exacerbation, Brown University, Providence, RI 02903, USA
- Department of Psychiatry and Human Behavior, Center for Alcohol and Addiction Studies, Brown University, Providence, RI 02903, USA
| | - Samantha E. Clark
- Department of Behavioral and Social Sciences, Center for Alcohol and Addiction Studies, Brown University, Providence, RI 02903, USA; (H.T.P.); (S.E.C.); (G.J.M.); (M.A.M.)
- Center for Addiction and Disease Risk Exacerbation, Brown University, Providence, RI 02903, USA
| | - Gabriel J. Muro
- Department of Behavioral and Social Sciences, Center for Alcohol and Addiction Studies, Brown University, Providence, RI 02903, USA; (H.T.P.); (S.E.C.); (G.J.M.); (M.A.M.)
- Center for Addiction and Disease Risk Exacerbation, Brown University, Providence, RI 02903, USA
| | - Mollie A. Monnig
- Department of Behavioral and Social Sciences, Center for Alcohol and Addiction Studies, Brown University, Providence, RI 02903, USA; (H.T.P.); (S.E.C.); (G.J.M.); (M.A.M.)
- Center for Addiction and Disease Risk Exacerbation, Brown University, Providence, RI 02903, USA
| |
Collapse
|
4
|
Kishimoto A, Ohtsubo R, Okada Y, Sugiyama K, Goda H, Yoshikawa T, Kohno M, Fukui K. Elucidation of composition of chlorine compounds in acidic sodium chlorite solution using ion chromatography. PLoS One 2023; 18:e0289534. [PMID: 37561805 PMCID: PMC10414608 DOI: 10.1371/journal.pone.0289534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2023] [Accepted: 07/20/2023] [Indexed: 08/12/2023] Open
Abstract
With the spread of coronavirus infections, the demand for disinfectants, such as a sodium chlorite solution, has increased worldwide. Sodium chlorite solution is a food additive and is used in a wide range of applications. There is evidence that chlorous acid or sodium chlorite is effective against various bacteria, but the actual mechanism is not well understood. One reason for this is that the composition of chlorine-based compounds contained in sodium chlorite solutions has not been clearly elucidated. The composition can vary greatly with pH. In addition, the conventional iodometric titration method, the N,N-diethyl-p-phenylenediamine sulfate (DPD) method and the absorption photometric method cannot clarify the composition. In this study, we attempted to elucidate the composition of a sodium chlorite solution using absorption spectrophotometry and ion chromatography (IC). IC is excellent for qualitative and quantitative analysis of trace ions. Through this, we aimed to develop an evaluation method that allows anyone to easily determine the bactericidal power of sodium chlorite. We found that commercially available sodium chlorite solution is 80% pure, with the remaining 20% potentially containing sodium hypochlorite solution. In addition, when sodium chlorite solution became acidified, its absorption spectrum exhibited a peak at 365 nm. Sodium chlorite solution is normally alkaline, and it cannot be measured by the DPD method, which is only applicable under acidic conditions. The presence of a peak at 365 nm indicates that the acidic sodium chlorite solution contains species with oxidizing power. On the other hand, the IC analysis showed a gradual decrease in chlorite ions in the acidic sodium chlorite solution. These results indicate that chlorite ions may not react with this DPD reagent, and other oxidizing species may be present in the acidic sodium chlorite solution. In summary, when a sodium chlorite solution becomes acidic, chlorine-based oxidizing species produce an absorption peak at 365 nm. Sodium hypochlorite and sodium chlorite solutions have completely different IC peak profiles. Although there are still many problems to be solved, we believe that the use of IC will facilitate the elucidation of the composition of sodium chlorite solution and its sterilization mechanism.
Collapse
Affiliation(s)
- Ayuta Kishimoto
- Department of Bioscience and Engineering, Molecular Cell Biology Laboratory, College of System Engineering and Science, Shibaura Institute of Technology, Fukasaku, Minuma-ku, Saitama, Japan
| | - Ryosuke Ohtsubo
- Department of Systems Engineering and Science, Molecular Cell Biology Laboratory, Shibaura Institute of Technology, Graduate School of Engineering and Science, Fukasaku, Minuma-ku, Saitama, Japan
| | - Yuta Okada
- Department of Bioscience and Engineering, Molecular Cell Biology Laboratory, College of System Engineering and Science, Shibaura Institute of Technology, Fukasaku, Minuma-ku, Saitama, Japan
| | - Kenta Sugiyama
- Department of Bioscience and Engineering, Molecular Cell Biology Laboratory, College of System Engineering and Science, Shibaura Institute of Technology, Fukasaku, Minuma-ku, Saitama, Japan
| | | | - Toshikazu Yoshikawa
- Louis Pasteur Center for Medical Research, Tanaka Monzen-cho, Sakyo-ku, Kyoto, Japan
- Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kajii-cho, Kamigyo-ku, Kyoto, Japan
| | - Masahiro Kohno
- Department of Bioscience and Engineering, Molecular Cell Biology Laboratory, College of System Engineering and Science, Shibaura Institute of Technology, Fukasaku, Minuma-ku, Saitama, Japan
- Louis Pasteur Center for Medical Research, Tanaka Monzen-cho, Sakyo-ku, Kyoto, Japan
| | - Koji Fukui
- Department of Bioscience and Engineering, Molecular Cell Biology Laboratory, College of System Engineering and Science, Shibaura Institute of Technology, Fukasaku, Minuma-ku, Saitama, Japan
- Department of Systems Engineering and Science, Molecular Cell Biology Laboratory, Shibaura Institute of Technology, Graduate School of Engineering and Science, Fukasaku, Minuma-ku, Saitama, Japan
| |
Collapse
|
5
|
Iyaniwura SA, Ringa N, Adu PA, Mak S, Janjua NZ, Irvine MA, Otterstatter M. Understanding the impact of mobility on COVID-19 spread: A hybrid gravity-metapopulation model of COVID-19. PLoS Comput Biol 2023; 19:e1011123. [PMID: 37172027 DOI: 10.1371/journal.pcbi.1011123] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2022] [Revised: 05/24/2023] [Accepted: 04/24/2023] [Indexed: 05/14/2023] Open
Abstract
The outbreak of the severe acute respiratory syndrome coronavirus 2 started in Wuhan, China, towards the end of 2019 and spread worldwide. The rapid spread of the disease can be attributed to many factors including its high infectiousness and the high rate of human mobility around the world. Although travel/movement restrictions and other non-pharmaceutical interventions aimed at controlling the disease spread were put in place during the early stages of the pandemic, these interventions did not stop COVID-19 spread. To better understand the impact of human mobility on the spread of COVID-19 between regions, we propose a hybrid gravity-metapopulation model of COVID-19. Our modeling framework has the flexibility of determining mobility between regions based on the distances between the regions or using data from mobile devices. In addition, our model explicitly incorporates time-dependent human mobility into the disease transmission rate, and has the potential to incorporate other factors that affect disease transmission such as facemasks, physical distancing, contact rates, etc. An important feature of this modeling framework is its ability to independently assess the contribution of each factor to disease transmission. Using a Bayesian hierarchical modeling framework, we calibrate our model to the weekly reported cases of COVID-19 in thirteen local health areas in Metro Vancouver, British Columbia (BC), Canada, from July 2020 to January 2021. We consider two main scenarios in our model calibration: using a fixed distance matrix and time-dependent weekly mobility matrices. We found that the distance matrix provides a better fit to the data, whilst the mobility matrices have the ability to explain the variance in transmission between regions. This result shows that the mobility data provides more information in terms of disease transmission than the distances between the regions.
Collapse
Affiliation(s)
- Sarafa A Iyaniwura
- British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
- Department of Mathematics and Institute of Applied Mathematics, University of British Columbia, Vancouver, British Columbia, Canada
| | - Notice Ringa
- British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
- School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
| | - Prince A Adu
- British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
- School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
| | - Sunny Mak
- British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
| | - Naveed Z Janjua
- British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
- School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
| | - Michael A Irvine
- British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
- Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, Canada
| | - Michael Otterstatter
- British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
- School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
| |
Collapse
|
6
|
Iyaniwura SA, Musa R, Kong JD. A generalized distributed delay model of COVID-19: An endemic model with immunity waning. MATHEMATICAL BIOSCIENCES AND ENGINEERING : MBE 2023; 20:5379-5412. [PMID: 36896550 DOI: 10.3934/mbe.2023249] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/18/2023]
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading worldwide for over two years, with millions of reported cases and deaths. The deployment of mathematical modeling in the fight against COVID-19 has recorded tremendous success. However, most of these models target the epidemic phase of the disease. The development of safe and effective vaccines against SARS-CoV-2 brought hope of safe reopening of schools and businesses and return to pre-COVID normalcy, until mutant strains like the Delta and Omicron variants, which are more infectious, emerged. A few months into the pandemic, reports of the possibility of both vaccine- and infection-induced immunity waning emerged, thereby indicating that COVID-19 may be with us for longer than earlier thought. As a result, to better understand the dynamics of COVID-19, it is essential to study the disease with an endemic model. In this regard, we developed and analyzed an endemic model of COVID-19 that incorporates the waning of both vaccine- and infection-induced immunities using distributed delay equations. Our modeling framework assumes that the waning of both immunities occurs gradually over time at the population level. We derived a nonlinear ODE system from the distributed delay model and showed that the model could exhibit either a forward or backward bifurcation depending on the immunity waning rates. Having a backward bifurcation implies that $ R_c < 1 $ is not sufficient to guarantee disease eradication, and that the immunity waning rates are critical factors in eradicating COVID-19. Our numerical simulations show that vaccinating a high percentage of the population with a safe and moderately effective vaccine could help in eradicating COVID-19.
Collapse
Affiliation(s)
- Sarafa A Iyaniwura
- Department of Mathematics and Institute of Applied Mathematics (IAM), University of British Columbia, Vancouver, British Columbia, Canada
| | - Rabiu Musa
- Faculty of Mathematics, Technion Israel Institute of Technology, Haifa 32000, Israel
| | - Jude D Kong
- Department of Mathematics and Statistics, York University, Toronto, Ontario, Canada
- Africa-Canada Artificial Intelligence and Data Innovation Consortium (ACADIC), York University, Toronto, Ontario, Canada
| |
Collapse
|
7
|
Advances in Nanoarchitectonics of Antimicrobial Tiles and a Quest for Anti-SARS-CoV-2 Tiles. J Inorg Organomet Polym Mater 2022; 32:3355-3367. [PMID: 35599970 PMCID: PMC9113380 DOI: 10.1007/s10904-022-02325-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2022] [Accepted: 03/23/2022] [Indexed: 10/27/2022]
|
8
|
Tao S, Bragazzi NL, Wu J, Mellado B, Kong JD. Harnessing Artificial Intelligence to assess the impact of nonpharmaceutical interventions on the second wave of the Coronavirus Disease 2019 pandemic across the world. Sci Rep 2022; 12:944. [PMID: 35042945 PMCID: PMC8766477 DOI: 10.1038/s41598-021-04731-5] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2021] [Accepted: 12/23/2021] [Indexed: 02/07/2023] Open
Abstract
In the present paper, we aimed to determine the influence of various non-pharmaceutical interventions (NPIs) enforced during the first wave of COVID-19 across countries on the spreading rate of COVID-19 during the second wave. For this purpose, we took into account national-level climatic, environmental, clinical, health, economic, pollution, social, and demographic factors. We estimated the growth of the first and second wave across countries by fitting a logistic model to daily-reported case numbers, up to the first and second epidemic peaks. We estimated the basic and effective (second wave) reproduction numbers across countries. Next, we used a random forest algorithm to study the association between the growth rate of the second wave and NPIs as well as pre-existing country-specific characteristics. Lastly, we compared the growth rate of the first and second waves of COVID-19. The top three factors associated with the growth of the second wave were body mass index, the number of days that the government sets restrictions on requiring facial coverings outside the home at all times, and restrictions on gatherings of 10 people or less. Artificial intelligence techniques can help scholars as well as decision and policy-makers estimate the effectiveness of public health policies, and implement "smart" interventions, which are as efficacious as stringent ones.
Collapse
Affiliation(s)
| | - Nicola Luigi Bragazzi
- Africa-Canada Artificial Intelligence and Data Innovation Consortium, Department of Mathematics and Statistics, York University, Toronto, ON, M3J 1P3, Canada
| | - Jianhong Wu
- Africa-Canada Artificial Intelligence and Data Innovation Consortium, Department of Mathematics and Statistics, York University, Toronto, ON, M3J 1P3, Canada
| | - Bruce Mellado
- School of Physics, Institute for Collider Particle Physics, University of the Witwatersrand, Johannesburg, South Africa
- iThemba LABS, National Research Foundation, Somerset West, South Africa
| | - Jude Dzevela Kong
- Africa-Canada Artificial Intelligence and Data Innovation Consortium, Department of Mathematics and Statistics, York University, Toronto, ON, M3J 1P3, Canada.
| |
Collapse
|
9
|
Rahbar Saadat Y, Hosseiniyan Khatibi SM, Zununi Vahed S, Ardalan M. Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza. Front Mol Biosci 2021; 8:725528. [PMID: 34527703 PMCID: PMC8435734 DOI: 10.3389/fmolb.2021.725528] [Citation(s) in RCA: 39] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Accepted: 08/11/2021] [Indexed: 12/23/2022] Open
Abstract
The ongoing pandemic illustrates limited therapeutic options for controlling SARS-CoV-2 infections, calling a need for additional therapeutic targets. The viral spike S glycoprotein binds to the human receptor angiotensin-converting enzyme 2 (ACE2) and then is activated by the host proteases. Based on the accessibility of the cellular proteases needed for SARS-S activation, SARS-CoV-2 entrance and activation can be mediated by endosomal (such as cathepsin L) and non-endosomal pathways. Evidence indicates that in the non-endosomal pathway, the viral S protein is cleaved by the furin enzyme in infected host cells. To help the virus enter efficiently, the S protein is further activated by the serine protease 2 (TMPRSS2), provided that the S has been cleaved by furin previously. In this review, important roles for host proteases within host cells will be outlined in SARS-CoV-2 infection and antiviral therapeutic strategies will be highlighted. Although there are at least five highly effective vaccines at this time, the appearance of the new viral mutations demands the development of therapeutic agents. Targeted inhibition of host proteases can be used as a therapeutic approach for viral infection.
Collapse
|
10
|
Buonerba A, Corpuz MVA, Ballesteros F, Choo KH, Hasan SW, Korshin GV, Belgiorno V, Barceló D, Naddeo V. Coronavirus in water media: Analysis, fate, disinfection and epidemiological applications. JOURNAL OF HAZARDOUS MATERIALS 2021; 415:125580. [PMID: 33735767 PMCID: PMC7932854 DOI: 10.1016/j.jhazmat.2021.125580] [Citation(s) in RCA: 44] [Impact Index Per Article: 14.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Revised: 03/02/2021] [Accepted: 03/02/2021] [Indexed: 05/03/2023]
Abstract
Considerable attention has been recently given to possible transmission of SARS-CoV-2 via water media. This review addresses this issue and examines the fate of coronaviruses (CoVs) in water systems, with particular attention to the recently available information on the novel SARS-CoV-2. The methods for the determination of viable virus particles and quantification of CoVs and, in particular, of SARS-CoV-2 in water and wastewater are discussed with particular regard to the methods of concentration and to the emerging methods of detection. The analysis of the environmental stability of CoVs, with particular regard of SARS-CoV-2, and the efficacy of the disinfection methods are extensively reviewed as well. This information provides a broad view of the state-of-the-art for researchers involved in the investigation of CoVs in aquatic systems, and poses the basis for further analyses and discussions on the risk associated to the presence of SARS-CoV-2 in water media. The examined data indicates that detection of the virus in wastewater and natural water bodies provides a potentially powerful tool for quantitative microbiological risk assessment (QMRA) and for wastewater-based epidemiology (WBE) for the evaluation of the level of circulation of the virus in a population. Assays of the viable virions in water media provide information on the integrity, capability of replication (in suitable host species) and on the potential infectivity. Challenges and critical issues relevant to the detection of coronaviruses in different water matrixes with both direct and surrogate methods as well as in the implementation of epidemiological tools are presented and critically discussed.
Collapse
Affiliation(s)
- Antonio Buonerba
- Sanitary Environmental Engineering Division (SEED), Department of Civil Engineering, University of Salerno, Via Giovanni Paolo II, Fisciano, SA, Italy; Inter-University Centre for Prediction and Prevention of Relevant Hazards (Centro Universitario per la Previsione e Prevenzione Grandi Rischi, C.U.G.RI.), Via Giovanni Paolo II, Fisciano, SA, Italy
| | - Mary Vermi Aizza Corpuz
- Environmental Engineering Program, National Graduate School of Engineering, University of the Philippines, 1101 Diliman, Quezon City, Philippines
| | - Florencio Ballesteros
- Environmental Engineering Program, National Graduate School of Engineering, University of the Philippines, 1101 Diliman, Quezon City, Philippines
| | - Kwang-Ho Choo
- Department of Environmental Engineering, Kyungpook National University (KNU), 80 Daehak-ro, Bukgu, Daegu 41566, Republic of Korea
| | - Shadi W Hasan
- Center for Membranes and Advanced Water Technology (CMAT), Department of Chemical Engineering, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates
| | - Gregory V Korshin
- Department of Civil and Environmental Engineering, University of Washington, Box 352700, Seattle, WA 98105-2700, United States
| | - Vincenzo Belgiorno
- Sanitary Environmental Engineering Division (SEED), Department of Civil Engineering, University of Salerno, Via Giovanni Paolo II, Fisciano, SA, Italy
| | - Damià Barceló
- Catalan Institute for Water Research (ICR-CERCA), H2O Building, Scientific and Technological Park of the University of Girona, Emili Grahit 101, 17003 Girona, Spain
| | - Vincenzo Naddeo
- Sanitary Environmental Engineering Division (SEED), Department of Civil Engineering, University of Salerno, Via Giovanni Paolo II, Fisciano, SA, Italy.
| |
Collapse
|
11
|
Mello IF, Squillante L, Gomes GO, Seridonio AC, de Souza M. Epidemics, the Ising-model and percolation theory: A comprehensive review focused on Covid-19. PHYSICA A 2021; 573:125963. [PMID: 33814681 PMCID: PMC8006539 DOI: 10.1016/j.physa.2021.125963] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/28/2020] [Revised: 02/16/2021] [Indexed: 05/03/2023]
Abstract
We revisit well-established concepts of epidemiology, the Ising-model, and percolation theory. Also, we employ a spin S = 1/2 Ising-like model and a (logistic) Fermi-Dirac-like function to describe the spread of Covid-19. Our analysis show that: (i) in many cases the epidemic curve can be described by a Gaussian-type function; (ii) the temporal evolution of the accumulative number of infections and fatalities follow a logistic function; (iii) the key role played by the quarantine to block the spread of Covid-19 in terms of an interacting parameter between people. In the frame of elementary percolation theory, we show that: (i) the percolation probability can be associated with the probability of a person being infected with Covid-19; (ii) the concepts of blocked and non-blocked connections can be associated, respectively, with a person respecting or not the social distancing. Yet, we make a connection between epidemiological concepts and well-established concepts in condensed matter Physics.
Collapse
Affiliation(s)
- Isys F Mello
- São Paulo State University (Unesp), IGCE - Physics Department, Rio Claro - SP, Brazil
| | - Lucas Squillante
- São Paulo State University (Unesp), IGCE - Physics Department, Rio Claro - SP, Brazil
| | - Gabriel O Gomes
- University of São Paulo, Department of Astronomy, SP, Brazil
| | - Antonio C Seridonio
- São Paulo State University (Unesp), Department of Physics and Chemistry, Ilha Solteira - SP, Brazil
| | - Mariano de Souza
- São Paulo State University (Unesp), IGCE - Physics Department, Rio Claro - SP, Brazil
| |
Collapse
|
12
|
Ram K, Thakur RC, Singh DK, Kawamura K, Shimouchi A, Sekine Y, Nishimura H, Singh SK, Pavuluri CM, Singh RS, Tripathi SN. Why airborne transmission hasn't been conclusive in case of COVID-19? An atmospheric science perspective. THE SCIENCE OF THE TOTAL ENVIRONMENT 2021; 773:145525. [PMID: 33940729 PMCID: PMC7984961 DOI: 10.1016/j.scitotenv.2021.145525] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/16/2020] [Revised: 01/15/2021] [Accepted: 01/26/2021] [Indexed: 05/06/2023]
Abstract
Airborne transmission is one of the routes for the spread of COVID-19 which is caused by inhalation of smaller droplets1 containing SARS-CoV-2 (i.e., either virus-laden particulate matter: PM and/or droplet nuclei) in an indoor environment. Notably, a significant fraction of the small droplets, along with respiratory droplets, is produced by both symptomatic and asymptomatic individuals during expiratory events such as breathing, sneezing, coughing and speaking. When these small droplets are exposed to the ambient environment, they may interact with PM and may remain suspended in the atmosphere even for several hours. Therefore, it is important to know the fate of these droplets and processes (e.g., physical and chemical) in the atmosphere to better understand airborne transmission. Therefore, we reviewed existing literature focussed on the transmission of SARS-CoV-2 in the spread of COVID-19 and present an environmental perspective on why airborne transmission hasn't been very conclusive so far. In addition, we discuss various environmental factors (e.g., temperature, humidity, etc.) and sampling difficulties, which affect the conclusions of the studies focussed on airborne transmission. One of the reasons for reduced emphasis on airborne transmission could be that the smaller droplets have less number of viruses as compared to larger droplets. Further, smaller droplets can evaporate faster, exposing SARS-CoV-2 within the small droplets to the environment, whose viability may further reduce. For example, these small droplets containing SARS-CoV-2 might also physically combine with or attach to pre-existing PM so that their behaviour and fate may be governed by PM composition. Thus, the measurement of their infectivity and viability is highly uncertain due to a lack of robust sampling system to separately collect virions in the atmosphere. We believe that the present review will help to minimize the gap in our understanding of the current pandemic and develop a robust epidemiological method for mortality assessment.
Collapse
Affiliation(s)
- Kirpa Ram
- Institute of Environment and Sustainable Development, Banaras Hindu University, Varanasi 221005, India.
| | - Roseline C Thakur
- Institute for Atmospheric and Earth System Research (INAR)/Physics, Faculty of Science, University of Helsinki, 00014 Helsinki, Finland.
| | - Dharmendra Kumar Singh
- French National Centre for Scientific Research (CNRS)/IRCE Lyon, 2 avenue Albert Einstein, Villeurbanne 69100, France.
| | - Kimitaka Kawamura
- Chubu Institute for Advanced Studies, Chubu University, Kasugai 487-8501, Japan.
| | - Akito Shimouchi
- School of Life and Health Sciences, Chubu University, Kasugai 487-8501, Japan.
| | - Yoshika Sekine
- Department of Chemistry, Tokai University, Hiratsuka, Kanagawa 25901292, Japan.
| | - Hidekazu Nishimura
- Virus Research Center, Clinical Research Division, Sendai Medical Center, Sendai, Japan.
| | - Sunit K Singh
- Laboratory of Molecular Virology & Immunology, Molecular Biology Unit, Faculty of Medicine, Institute of Medical Sciences (IMS), Banaras Hindu University (BHU), Varanasi 221005, India.
| | - Chandra Mouli Pavuluri
- Institute of Surface-Earth System Science, School of Earth System Science, Tianjin University, Tianjin 300072, China.
| | - R S Singh
- Department of Chemical Engineering, IIT (BHU), Varanasi 221005, Uttar Pradesh, India.
| | - S N Tripathi
- Department of Civil Engineering, Centre for Environmental Science and Engineering, Indian Institute of Technology Kanpur, Kanpur 208016, India.
| |
Collapse
|
13
|
Brayda-Bruno M, Giorgino R, Gallazzi E, Morelli I, Manfroni F, Briguglio M, Accetta R, Mangiavini L, Peretti GM. How SARS-CoV-2 Pandemic Changed Traumatology and Hospital Setting: An Analysis of 498 Fractured Patients. J Clin Med 2021; 10:jcm10122585. [PMID: 34208115 PMCID: PMC8230877 DOI: 10.3390/jcm10122585] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2021] [Revised: 06/02/2021] [Accepted: 06/10/2021] [Indexed: 12/11/2022] Open
Abstract
Background: SARS-CoV-2 pandemic is one of the biggest challenges for many health systems in the world, making lots of them overwhelmed by the enormous pressure to manage patients. We reported our Institutional Experience, with specific aims to describe the distribution and type of treated injuries, and the organizational setup of our hospital. Methods: Data of fractured patients admitted for surgical treatment in the time frames 9 March 2020–4 May 2020 and 1 March 2019–31 May 2019 were collected and compared. Furthermore, surgery duration and some parameters of effectiveness in health management were compared. Results: A total of 498 patients were included. Mean age significantly lower age in 2019 and femoral fractures were significantly more frequent 2020. Mean surgery time was significantly longer in 2020. Mortality rate difference between the two years was found to be statistically significant. Time interval between diagnosis and surgery and between diagnosis and discharge/decease was significantly lower in 2020. In 2020, no patient admitted with a negative swab turned positive in any of the following tests for SARS-CoV-2. Conclusions: The COVID-19 pandemic has modified the epidemiology of hospitalized patients for traumatic reasons, leading to an increased admission of older patients with femoral fractures. Nevertheless, our institutional experience showed that an efficient change in the hospital organization, with an improvement of several parameters of effectiveness in health management, led to a null infection rate between patients.
Collapse
Affiliation(s)
- Marco Brayda-Bruno
- IRCCS Orthopedic Institute Galeazzi, 20144 Milan, Italy; (M.B.-B.); (F.M.); (M.B.); (R.A.); (L.M.); (G.M.P.)
| | - Riccardo Giorgino
- Residency Program in Orthopedics and Traumatology, University of Milan, 20122 Milan, Italy
- Correspondence:
| | - Enrico Gallazzi
- Ortopedia e Traumatologia 3, ASST Centro Specialistico Ortopedico Traumatologico G. Pini–CTO, 20122 Milan, Italy;
| | - Ilaria Morelli
- U.O.C. Ortopedia e Traumatologia Nuovo Ospedale di Legnano ASST Ovest Milanese, 20025 Legnano, Italy;
| | - Francesca Manfroni
- IRCCS Orthopedic Institute Galeazzi, 20144 Milan, Italy; (M.B.-B.); (F.M.); (M.B.); (R.A.); (L.M.); (G.M.P.)
| | - Matteo Briguglio
- IRCCS Orthopedic Institute Galeazzi, 20144 Milan, Italy; (M.B.-B.); (F.M.); (M.B.); (R.A.); (L.M.); (G.M.P.)
| | - Riccardo Accetta
- IRCCS Orthopedic Institute Galeazzi, 20144 Milan, Italy; (M.B.-B.); (F.M.); (M.B.); (R.A.); (L.M.); (G.M.P.)
| | - Laura Mangiavini
- IRCCS Orthopedic Institute Galeazzi, 20144 Milan, Italy; (M.B.-B.); (F.M.); (M.B.); (R.A.); (L.M.); (G.M.P.)
- Department of Biomedical Sciences for Health, University of Milan, 20122 Milan, Italy
| | - Giuseppe Maria Peretti
- IRCCS Orthopedic Institute Galeazzi, 20144 Milan, Italy; (M.B.-B.); (F.M.); (M.B.); (R.A.); (L.M.); (G.M.P.)
- Department of Biomedical Sciences for Health, University of Milan, 20122 Milan, Italy
| |
Collapse
|
14
|
Davis RE, Sharma M, Simon KE, Wilkerson AH. Conceptualization of college students' COVID-19 related mask-wearing behaviors using the Multi-Theory Model of health behavior change. Health Promot Perspect 2021; 11:194-201. [PMID: 34195043 PMCID: PMC8233670 DOI: 10.34172/hpp.2021.24] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2021] [Accepted: 04/06/2021] [Indexed: 12/20/2022] Open
Abstract
Background: Recommendations and policies, regarding the use of face coverings, have been instituted to control transmission of coronavirus disease 2019 (COVID-19). Understanding of psychosocial factors related to the use of face coverings within the context of COVID-19 is needed. This study aimed to conceptualize mask-wearing behavior among students using the Multi-theory Model (MTM) of behavior change. Methods: In October 2020, students (n = 595) enrolled in a large public southeastern US university were recruited to participate in a cross-sectional survey, using a valid and reliable instrument. Univariate, bivariate, and multivariate techniques described mask-wearing behavior and differentiated theoretical drivers of mask-wearing between individuals compliant and non-compliant with guidelines. Results: Compliant individuals reported significantly higher scores (P <0.05) for initiation and sustenance of mask-wearing, participatory dialogue, behavioral confidence, emotional transformation, practice for change, changes in the social environment, and significantly lower scores for disadvantage. Among multivariable models, all theoretical predictors exhibited significant relationships to their respective outcomes (initiation and sustenance). Specifically, MTM constructs explained approximately 35% of variance in initiation (R2 = 0.346, F(3,526) = 94.32, P <0.001) and 33% of variance in sustenance of mask wearing (R2 = 0.328, F(3,529) = 87.71, P <0.001) for compliant individuals. Behavioral confidence and emotional transformation exhibited the strongest relationships to initiation (ß = 0.403, P <0.001) and sustenance (ß = 0.450, P <0.001), respectively. Conclusion: Findings suggest a need to design educational programming based on the MTM to promote mask-wearing behavior among laggards who defy face mask guidelines, recommendations, and mandates.
Collapse
Affiliation(s)
- Robert E Davis
- Substance Use and Mental Health Laboratory, Department of Health, Human Performance and Recreation, University of Arkansas, 155 N Stadium Drive, HPER 308, Fayetteville, AR 72701, USA
| | - Manoj Sharma
- Social and Behavioral Health, Department of Environmental & Occupational Health, School of Public Health, University of Nevada, Las Vegas, NV, USA
| | - Kayla E Simon
- Substance Use and Mental Health Laboratory, Department of Health, Human Performance and Recreation, University of Arkansas, 155 N Stadium Drive, HPER 308, Fayetteville, AR 72701, USA
| | - Amanda H Wilkerson
- Department of Human Environmental Sciences, University of Alabama, 481 Russell Hall, Box 8 70311, Tuscaloosa, AL, 35487, USA
| |
Collapse
|
15
|
Kim N, Han K, Su PC, Kim I, Yoon YJ. A rotationally focused flow (RFF) microfluidic biosensor by density difference for early-stage detectable diagnosis. Sci Rep 2021; 11:9277. [PMID: 33927298 PMCID: PMC8085145 DOI: 10.1038/s41598-021-88647-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2020] [Accepted: 03/12/2021] [Indexed: 02/07/2023] Open
Abstract
Label-free optical biosensors have received tremendous attention in point-of-care testing, especially in the emerging pandemic, COVID-19, since they advance toward early-detection, rapid, real-time, ease-of-use, and low-cost paradigms. Protein biomarkers testings require less sample modification process compared to nucleic-acid biomarkers'. However, challenges always are in detecting low-concentration for early-stage diagnosis. Here we present a Rotationally Focused Flow (RFF) method to enhance sensitivity(wavelength shift) of label-free optical sensors by increasing the detection probability of protein-based molecules. The RFF is structured by adding a less-dense fluid to focus the target-fluid in a T-shaped microchannel. It is integrated with label-free silicon microring resonators interacting with biotin-streptavidin. The suggested mechanism has demonstrated 0.19 fM concentration detection along with a significant magnitudes sensitivity enhancement compared to single flow methods. Verified by both CFD simulations and fluorescent flow-experiments, this study provides a promising proof-of-concept platform for next-generation lab-on-a-chip bioanalytics such as ultrafast and early-detection of COVID-19.
Collapse
Affiliation(s)
- Noori Kim
- Department of Electrical and Electronic Engineering, Newcastle University in Singapore, 172A Ang Mo Kio Avenue 8, 05-01 SIT@NYP Building, Singapore, 567739, Singapore
- School of Mechanical and Aerospace Engineering, Nanyang Technological University (NTU), Singapore, 639798, Singapore
| | - Kyungsup Han
- School of Mechanical and Aerospace Engineering, Nanyang Technological University (NTU), Singapore, 639798, Singapore
| | - Pei-Chen Su
- School of Mechanical and Aerospace Engineering, Nanyang Technological University (NTU), Singapore, 639798, Singapore
| | - Insup Kim
- Department of Mechanical Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Korea
| | - Yong-Jin Yoon
- School of Mechanical and Aerospace Engineering, Nanyang Technological University (NTU), Singapore, 639798, Singapore.
- Department of Mechanical Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, 34141, Korea.
| |
Collapse
|
16
|
Mohammed Sheata I, Smith SR, Kamel H, Varrassi G, Imani F, Dayani A, Myrcik D, Urits I, Viswanath O, Taha SS. Pulmonary Embolism and Cardiac Tamponade in Critical Care Patients with COVID-19; Telemedicine's Role in Developing Countries: Case Reports and Literature Review. Anesth Pain Med 2021; 11:e113752. [PMID: 34336628 PMCID: PMC8314078 DOI: 10.5812/aapm.113752] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2021] [Revised: 03/15/2021] [Accepted: 03/26/2021] [Indexed: 01/30/2023] Open
Abstract
INTRODUCTION In this study, two cases that demonstrate the importance of bedside echocardiography and hands-off telemedicine technology for diagnosis and intervention in patients with coronavirus disease 2019 (COVID-19) are discussed. CASE PRESENTATION We report two cases of cardiac emergency associated with COVID-19. Case 1 is a 50-year-old female patient with chronic hypertension and chronic renal failure. Case 2 is a 64-year-old female with atrial fibrillation and recent stroke. Both were admitted to an isolation intensive care unit that was designated specifically to patients with COVID-19. CONCLUSIONS During admission, both patients had sudden deterioration characterized by oxygen desaturation and hypotension necessitating inotropic support. As a result, for both patients, bedside echocardiography was performed by the attending intensivist. Echocardiographic findings showed cardiac tamponade and acute pulmonary embolism, respectively, which were confirmed by a cardiologist through telemedicine technology. Proper emergency management was initiated, and both patients recovered well. Limited bedside transthoracic echocardiography had a front-line impact on the treatment and outcome of the two patients with COVID-19. By implementing telemedicine technology, the lives of two patients were saved, demonstrating the significance of telemedicine in isolation intensive care units in the developing countries during the COVID-19 pandemic.
Collapse
Affiliation(s)
| | | | - Heba Kamel
- Congenital and Structural Heart Disease Unit, Cardiology Department, Ain Shams University, Cairo, Egypt
| | | | - Farnad Imani
- Pain Research Center, Department of Anesthesiology and Pain Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - Abdolreza Dayani
- Cardiac Anesthesia Department, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
| | - Dariusz Myrcik
- Department of Internal Medicine, University of Silesia in Katowice, Bytom, Poland
| | - Ivan Urits
- Southcoast Health, Southcoast Physicians Group Pain Medicine, Wareham, Massachusetts, USA
- Louisiana State University Health Sciences Center, Department of Anesthesiology, Shreveport, Louisiana, USA
| | - Omar Viswanath
- Louisiana State University Health Sciences Center, Department of Anesthesiology, Shreveport, Louisiana, USA
- University of Arizona College of Medicine-Phoenix, Department of Anesthesiology, Phoenix, Arizona, USA
- Creighton University School of Medicine, Department of Anesthesiology, Omaha, Nebraska, USA
- Valley Pain Consultants, Envision Physician Services, Phoenix, Arizona, USA
| | | |
Collapse
|
17
|
Caruso FP, Scala G, Cerulo L, Ceccarelli M. A review of COVID-19 biomarkers and drug targets: resources and tools. Brief Bioinform 2021; 22:701-713. [PMID: 33279954 PMCID: PMC7799271 DOI: 10.1093/bib/bbaa328] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Revised: 10/05/2020] [Accepted: 10/23/2020] [Indexed: 01/18/2023] Open
Abstract
The stratification of patients at risk of progression of COVID-19 and their molecular characterization is of extreme importance to optimize treatment and to identify therapeutic options. The bioinformatics community has responded to the outbreak emergency with a set of tools and resource to identify biomarkers and drug targets that we review here. Starting from a consolidated corpus of 27 570 papers, we adopt latent Dirichlet analysis to extract relevant topics and select those associated with computational methods for biomarker identification and drug repurposing. The selected topics span from machine learning and artificial intelligence for disease characterization to vaccine development and to therapeutic target identification. Although the way to go for the ultimate defeat of the pandemic is still long, the amount of knowledge, data and tools generated so far constitutes an unprecedented example of global cooperation to this threat.
Collapse
|
18
|
Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths. Aging (Albany NY) 2021; 13:6289-6297. [PMID: 33711813 PMCID: PMC7993687 DOI: 10.18632/aging.202819] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2020] [Accepted: 03/04/2021] [Indexed: 12/17/2022]
Abstract
Objectives: To retrospectively evaluate the clinical and immunological characteristics of patients who died of COVID-19 and to identify patients at high risk of death at an early stage and reduce their mortality. Results: Total white blood cell count, neutrophil count and C-reactive protein were significantly higher in patients who died of COVID-19 than those who recovered from it (p < 0.05), but the total lymphocyte count, CD4 + T cells, CD8 + T cells, B cells and natural killer cells were significantly lower when compared in the same groups. Multiple logistic regression analysis showed that increased D-dimer, decreased CD4 + T cells and increased neutrophils were risk factors for mortality. Further multiple COX regression demonstrated that neutrophil ≥ 5.27 × 109/L increased the risk of death in COVID-19 patients after adjustment for age and gender. However, CD4 + T cells ≥ 260/μL appeared to reduce the risk of death. Conclusion: SARS-CoV-2 infection led to a significant decrease of lymphocytes, and decreased CD4 + T cell count was a risk factor for COVID-19 patients to develop severe disease and death. Methods: This study included 190 hospitalized COVID-19 patients from January 30, 2020 to March 4, 2020 in Wuhan, China, of whom 85 died and 105 recovered. Two researchers independently collected the clinical and laboratory data from electronic medical records.
Collapse
|
19
|
Segreto R, Deigin Y. The genetic structure of SARS-CoV-2 does not rule out a laboratory origin: SARS-COV-2 chimeric structure and furin cleavage site might be the result of genetic manipulation. Bioessays 2021; 43:e2000240. [PMID: 33200842 PMCID: PMC7744920 DOI: 10.1002/bies.202000240] [Citation(s) in RCA: 55] [Impact Index Per Article: 18.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2020] [Revised: 10/16/2020] [Accepted: 10/22/2020] [Indexed: 12/20/2022]
Abstract
Severe acute respiratory syndrome-coronavirus (SARS-CoV)-2's origin is still controversial. Genomic analyses show SARS-CoV-2 likely to be chimeric, most of its sequence closest to bat CoV RaTG13, whereas its receptor binding domain (RBD) is almost identical to that of a pangolin CoV. Chimeric viruses can arise via natural recombination or human intervention. The furin cleavage site in the spike protein of SARS-CoV-2 confers to the virus the ability to cross species and tissue barriers, but was previously unseen in other SARS-like CoVs. Might genetic manipulations have been performed in order to evaluate pangolins as possible intermediate hosts for bat-derived CoVs that were originally unable to bind to human receptors? Both cleavage site and specific RBD could result from site-directed mutagenesis, a procedure that does not leave a trace. Considering the devastating impact of SARS-CoV-2 and importance of preventing future pandemics, researchers have a responsibility to carry out a thorough analysis of all possible SARS-CoV-2 origins.
Collapse
Affiliation(s)
- Rossana Segreto
- Department of MicrobiologyUniversity of InnsbruckInnsbruckAustria
| | - Yuri Deigin
- Youthereum Genetics Inc.TorontoOntarioCanada
| |
Collapse
|
20
|
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infects both children and adults but epidemiological and clinical data demonstrate that children are less likely to have a severe disease course or die. Furthermore, asthmatic children show less severe disease manifestations when infected with SARS-CoV-2 comparing to adults. This review focuses on SARS-CoV-2 and childhood asthma interaction and aims at summarizing the current knowledge of the potential mechanisms that ameliorate disease symptomatology in asthmatic children.
Collapse
Affiliation(s)
| | - Ahmad Kantar
- Pediatric Asthma and Cough Centre, Instituti Ospedalieri Bergamaschi, University and Research Hospitals, Bergamo, Italy
| |
Collapse
|
21
|
Shariare MH, Parvez MAK, Karikas GA, Kazi M. The growing complexity of COVID-19 drug and vaccine candidates: challenges and critical transitions. J Infect Public Health 2021; 14:214-220. [PMID: 33493917 PMCID: PMC7833287 DOI: 10.1016/j.jiph.2020.12.009] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2020] [Revised: 11/09/2020] [Accepted: 12/02/2020] [Indexed: 12/15/2022] Open
Abstract
COVID-19 has nowadays affected almost all our societies and global health systems. The latest deadly pandemic has heavily influenced both life and livelihood worldwide. SARS-CoV-2 is the causative organism of COVID-19, that is spreading and infecting significantly higher compared to other coronavirus, due to its constant mutation characteristics. At present although several extensive clinical trials are ongoing, neither approved drug therapy nor any vaccine are available to safely fight SARS-CoV-2. However, a progressive race among numerous research groups to discover a radical cure for the COVID-19 is under way. This review aims to provide an updated insight of the current research, development and trials on repurposing existing drugs and preventive intervention for COVID-19, along with the related issues, complexities and challenges, especially after the observed high transmissibility lately.
Collapse
Affiliation(s)
| | - Md Anowar Khasru Parvez
- Department of Microbiology, Jahangirnagar University, Dhaka, Bangladesh; Treasurer, Pabna University of Science and Technology, Pabna, Bangladesh
| | - George A Karikas
- Department of Biomedical Sciences, University of West Attica, Athens, Greece
| | - Mohsin Kazi
- Department of Pharmaceutics, College of Pharmaceutics, King Saud University, Riyadh, KSA.
| |
Collapse
|
22
|
Application of Optimal Control of Infectious Diseases in a Model-Free Scenario. SN COMPUTER SCIENCE 2021; 2:405. [PMID: 34396152 PMCID: PMC8349133 DOI: 10.1007/s42979-021-00794-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/05/2020] [Accepted: 07/25/2021] [Indexed: 02/07/2023]
Abstract
Optimal control for infectious diseases has received increasing attention over the past few decades. In general, a combination of cost state variables and control effort have been applied as cost indices. Many important results have been reported. Nevertheless, it seems that the interpretation of the optimal control law for an epidemic system has received less attention. In this paper, we have applied Pontryagin's maximum principle to develop an optimal control law to minimize the number of infected individuals and the vaccination rate. We have adopted the compartmental model SIR to test our technique. We have shown that the proposed control law can give some insights to develop a control strategy in a model-free scenario. Numerical examples show a reduction of 50% in the number of infected individuals when compared with constant vaccination. There is not always a prior knowledge of the number of susceptible, infected, and recovered individuals required to formulate and solve the optimal control problem. In a model-free scenario, a strategy based on the analytic function is proposed, where prior knowledge of the scenario is not necessary. This insight can also be useful after the development of a vaccine to COVID-19, since it shows that a fast and general cover of vaccine worldwide can minimize the number of infected, and consequently the number of deaths. The considered approach is capable of eradicating the disease faster than a constant vaccination control method.
Collapse
|
23
|
Padhy S, Dimri VP. Apparent scaling of virus surface roughness-An example from the pandemic SARS-nCoV. PHYSICA D. NONLINEAR PHENOMENA 2020; 414:132704. [PMID: 32901164 PMCID: PMC7471937 DOI: 10.1016/j.physd.2020.132704] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/01/2020] [Revised: 08/24/2020] [Accepted: 08/25/2020] [Indexed: 05/08/2023]
Abstract
This paper investigates the scaling of the surface roughness of coronavirus, including the SARS-nCoV based on fractal and spectral analyses of their published electron microscopy images. The box-counting fractal dimensions obtained are subjected to ANOVA tests for statistical significance. Results show that the SARS-nCoV particles could not statistically be resolved by their shape on the basis of the fractal dimension values, but they could be distinguished from the earlier SARS-CoV particles. MANOVA test results require interaction of factors used for classifying virions into different types. The topological entropies, a measure of randomness in a system, measured for the images of varying size show correlation with the fractal dimensions. Spectral analyses of our data show a departure from power-law self-similarity, suggesting an apparent scaling of surface roughness over a band of maximum an order of magnitude. The spectral crossover that corresponds to characteristic length scale may represent average viral size. Our results may be useful in inferring the nature of surface-contact between the viral and human cell, causing infection and also in providing clues for new drugs, although it is too early to say. In addition, limitations of this study, including possible ways to avoid the bias in scaling exponents due to the use of different techniques are discussed.
Collapse
Affiliation(s)
- Simanchal Padhy
- CSIR-National Geophysical Research Institute, Hyderabad, India
| | - Vijay P Dimri
- CSIR-National Geophysical Research Institute, Hyderabad, India
| |
Collapse
|
24
|
Sikander M, Malik S, Rodriguez A, Yallapu MM, Narula AS, Satapathy SK, Dhevan V, Chauhan SC, Jaggi M. Role of Nutraceuticals in COVID-19 Mediated Liver Dysfunction. Molecules 2020; 25:E5905. [PMID: 33322162 PMCID: PMC7764432 DOI: 10.3390/molecules25245905] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2020] [Revised: 12/05/2020] [Accepted: 12/09/2020] [Indexed: 01/08/2023] Open
Abstract
COVID-19 is known as one of the deadliest pandemics of the century. The rapid spread of this deadly virus at incredible speed has stunned the planet and poses a challenge to global scientific and medical communities. Patients with COVID-19 are at an increased risk of co-morbidities associated with liver dysfunction and injury. Moreover, hepatotoxicity induced by antiviral therapy is gaining importance and is an area of great concern. Currently, alternatives therapies are being sought to mitigate hepatic damage, and there has been growing interest in the research on bioactive phytochemical agents (nutraceuticals) due to their versatility in health benefits reported in various epidemiological studies. Therefore, this review provides information and summarizes the juncture of antiviral, immunomodulatory, and hepatoprotective nutraceuticals that can be useful during the management of COVID-19.
Collapse
Affiliation(s)
- Mohammed Sikander
- Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA; (M.S.); (S.M.); (A.R.); (M.M.Y.); (S.C.C.)
- South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA
| | - Shabnam Malik
- Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA; (M.S.); (S.M.); (A.R.); (M.M.Y.); (S.C.C.)
- South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA
| | - Anyssa Rodriguez
- Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA; (M.S.); (S.M.); (A.R.); (M.M.Y.); (S.C.C.)
- South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA
| | - Murali M. Yallapu
- Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA; (M.S.); (S.M.); (A.R.); (M.M.Y.); (S.C.C.)
- South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA
| | - Acharan S. Narula
- Narula Research, LLC, 107 Boulder Bluff, Chapel Hill, NC 27516, USA;
| | - Sanjaya K. Satapathy
- Division of Hepatology, Department of Internal Medicine, Sandra Atlas Bass Center for Liver Diseases and Transplantation, Barbara and Zucker School of Medicine, Northwell Health, Manhasset, NY 11030, USA;
| | - Vijian Dhevan
- Department of Surgery, School of Medicine, University of Texas Rio Grande Valley, Edinburg, TX 78539, USA;
| | - Subhash C. Chauhan
- Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA; (M.S.); (S.M.); (A.R.); (M.M.Y.); (S.C.C.)
- South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA
| | - Meena Jaggi
- Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA; (M.S.); (S.M.); (A.R.); (M.M.Y.); (S.C.C.)
- South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA
| |
Collapse
|
25
|
Zhong M, Lin B, Pathak JL, Gao H, Young AJ, Wang X, Liu C, Wu K, Liu M, Chen JM, Huang J, Lee LH, Qi CL, Ge L, Wang L. ACE2 and Furin Expressions in Oral Epithelial Cells Possibly Facilitate COVID-19 Infection via Respiratory and Fecal-Oral Routes. Front Med (Lausanne) 2020; 7:580796. [PMID: 33363183 PMCID: PMC7758442 DOI: 10.3389/fmed.2020.580796] [Citation(s) in RCA: 52] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2020] [Accepted: 11/02/2020] [Indexed: 12/15/2022] Open
Abstract
Background: Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that mainly transfers from human to human via respiratory and gastrointestinal routes. The S-glycoprotein in the virus is the key factor for the entry of SARS-CoV-2 into the cell, which contains two functional domains: S1 is an angiotensin-converting enzyme 2 (ACE2) receptor binding domain, and S2 is necessary for fusion of the coronavirus and cell membranes. Moreover, it has been reported that ACE2 is likely to be the receptor for SARS-CoV-2. In addition, mRNA level expression of Furin enzyme and ACE2 receptor had been reported in airway epithelia, cardiac tissue, and enteric canals. However, the expression patterns of ACE2 and Furin in different cell types of oral tissues are still unclear. Methods: In order to investigate the potential infective channel of the new coronavirus via the oropharyngeal cavity, we analyze the expression of ACE2 and Furin in human oral mucosa using the public single-cell sequence datasets. Furthermore, immunohistochemistry was performed in mucosal tissue from different oral anatomical sites to confirm the expression of ACE2 and Furin at the protein level. Results: The bioinformatics results indicated the differential expression of ACE2 and Furin on epithelial cells from different oral anatomical sites. Immunohistochemistry results revealed that both the ACE2-positive and Furin-positive cells in the target tissues were mainly positioned in the epithelial layers, partly expressed in fibroblasts, further confirming the bioinformatics results. Conclusions: Based on these findings, we speculated that SARS-CoV-2 could invade oral mucosal cells through two possible routes: binding to the ACE2 receptor and fusion with cell membrane activated by Furin protease. Our results indicated that oral mucosa tissues are susceptible to SARS-CoV-2 that could facilitate COVID-19 infection via respiratory and fecal-oral routes.
Collapse
Affiliation(s)
- Mei Zhong
- Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, China
| | - Bingpeng Lin
- Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, China
| | - Janak L. Pathak
- Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, China
- Institute of Oral Disease, Guangzhou Medical University, Guangzhou, China
| | - Hongbin Gao
- Key Laboratory of Guangdong Laboratory Animals, Guangdong Laboratory Animals Monitoring Institute, Guangzhou, China
| | | | - Xinhong Wang
- Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, China
| | - Chang Liu
- Stomatology School of Ji'nan University, Guangzhou, China
| | - Kaibin Wu
- Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, China
| | - Mingxiao Liu
- Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, China
| | - Jian-ming Chen
- Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, China
| | - Jiangyong Huang
- Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, China
| | - Learn-Han Lee
- Novel Bacteria and Drug Discovery Research Group (NBDD), Microbiome and Bioresource Research Strength (MBRS), Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia
| | - Cui-ling Qi
- School of Life Science and Biopharmaceutics, Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou, China
| | - Linhu Ge
- Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, China
- Institute of Oral Disease, Guangzhou Medical University, Guangzhou, China
| | - Lijing Wang
- Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou, China
- School of Life Science and Biopharmaceutics, Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou, China
| |
Collapse
|
26
|
Faried A, Dian S, Halim D, Hermanto Y, Pratama DMA, Arifin MZ. The neurological significance of COVID-19: Lesson learn from the pandemic. INTERDISCIPLINARY NEUROSURGERY : ADVANCED TECHNIQUES AND CASE MANAGEMENT 2020; 22:100809. [PMID: 33520665 PMCID: PMC7832154 DOI: 10.1016/j.inat.2020.100809] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/11/2020] [Accepted: 06/14/2020] [Indexed: 12/24/2022]
Abstract
Coronavirus Infectious Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously known as 2019 novel coronavirus) is an emerging and rapidly evolving health issue that has been widespread globally and become a pandemic. The typical symptoms of COVID-19 are: a cough, shortness of breath and a fever; from the initial estimates, about 15% of COVID-19 patients present with severe respiratory symptoms and requires hospitalization and intensive care. Recent accumulated evidences showed that the neurological insults also occurred in patients with COVID-19, ranging from mild headache to severe neurological symptoms. In this review, we summarize the COVID-19 and neurological significance of COVID-19.
Collapse
Key Words
- ACE2, Angiotensin converting enzyme 2
- ADEM, Acute disseminated encephalomyelitis
- ANE, Acute necrotizing encephalopathy
- ARDS, Acute respiratory distress syndrome
- CNS, Central nervous system
- COVID-19 complications
- COVID-19, Coronavirus Infectious Disease 2019
- Coronavirus
- IL, Interleukin
- MOF, Multiple organs failure
- Neurological significance
- SARS-CoV, Severe acute respiratory coronavirus syndrome
- SARS-CoV-2, Severe acute respiratory coronavirus 2 syndrome
- SARS-Cov-2
Collapse
Affiliation(s)
- Ahmad Faried
- Department of Neurosurgery, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung 40161, West Java, Indonesia
- Oncology & Stem Cell Working Group, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung 40161, West Java, Indonesia
| | - Sofiati Dian
- Department of Neurology, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung 40161, West Java, Indonesia
| | - Danny Halim
- Department of Neurosurgery, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung 40161, West Java, Indonesia
- Oncology & Stem Cell Working Group, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung 40161, West Java, Indonesia
| | - Yulius Hermanto
- Oncology & Stem Cell Working Group, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung 40161, West Java, Indonesia
| | - Dilli Marayuzan Akbar Pratama
- Department of Neurosurgery, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung 40161, West Java, Indonesia
| | - Muhammad Zafrullah Arifin
- Department of Neurosurgery, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung 40161, West Java, Indonesia
| |
Collapse
|
27
|
Gaudin A, Badran Z, Chevalier V, Aubeux D, Prud'homme T, Amador del Valle G, Cloitre A. COVID-19 and Oral Fluids. FRONTIERS IN DENTAL MEDICINE 2020. [DOI: 10.3389/fdmed.2020.00008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
|
28
|
Space-Time Variation and Spatial Differentiation of COVID-19 Confirmed Cases in Hubei Province Based on Extended GWR. ISPRS INTERNATIONAL JOURNAL OF GEO-INFORMATION 2020. [DOI: 10.3390/ijgi9090536] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Clarifying the regional transmission mechanism of COVID-19 has practical significance for effective protection. Taking 103 county-level regions of Hubei Province as an example, and taking the fastest-spreading stage of COVID-19, which lasted from 29 January 2020, to 29 February 2020, as the research period, we systematically analyzed the population migration, spatio-temporal variation pattern of COVID-19, with emphasis on the spatio-temporal differences and scale effects of related factors by using the daily sliding, time-ordered data analysis method, combined with extended geographically weighted regression (GWR). The results state that: Population migration plays a two-way role in COVID-19 variation. The emigrants’ and immigrants’ population of Wuhan city accounted for 3.70% and 73.05% of the total migrants’ population respectively; the restriction measures were not only effective in controlling the emigrants, but also effective in preventing immigrants. COVID-19 has significant spatial autocorrelation, and spatio-temporal differentiation has an effect on COVID-19. Different factors have different degrees of effect on COVID-19, and similar factors show different scale effects. Generally, the pattern of spatial differentiation is a transitional pattern of parallel bands from east to west, and also an epitaxial radiation pattern centered in the Wuhan 1 + 8 urban circle. This paper is helpful to understand the spatio-temporal evolution of COVID-19 in Hubei Province, so as to provide a reference for similar epidemic prevention.
Collapse
|
29
|
Shehata IM, Elhassan A, Jung JW, Urits I, Viswanath O, Kaye AD. Elective cardiac surgery during the COVID-19 pandemic: Proceed or postpone? Best Pract Res Clin Anaesthesiol 2020; 34:643-650. [PMID: 33004173 PMCID: PMC7368150 DOI: 10.1016/j.bpa.2020.07.005] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2020] [Accepted: 07/15/2020] [Indexed: 01/01/2023]
Abstract
During this coronavirus disease 2019 (COVID-19) pandemic, there is an international call to postpone all elective surgeries. Cardiac surgery carries a combined risk for cardiac patients, who are at risk for higher complications of COVID-19, and healthcare workers. In response to the COVID-19 pandemic, the American College of Surgeons and the American Society of Anesthesiologists recommended a sustained reduction in the rate of new COVID-19 cases for 14 days before the resumption of the elective surgery, but postponing surgery may impact patients' daily activities and increase the risk the of deterioration of their cardiac condition. We will discuss the risks and benefits of the decision whether to postpone or proceed with elective cardiac surgical procedures during the escalating COVID-19 pandemic considering the specific risk of the cardiac patients, the unique characteristics of the surgery, and the international health system capacity.
Collapse
Affiliation(s)
| | - Amir Elhassan
- Desert Regional Medical Center, Cardiothoracic Anesthesia, Palm Springs, CA, USA
| | - Jai Won Jung
- Georgetown University School of Medicine, Washington, DC, USA
| | - Ivan Urits
- Beth Israel Deaconess Medical Center, Department of Anesthesia, Critical Care, and Pain Medicine, Harvard Medical School, Boston, MA, USA.
| | - Omar Viswanath
- Valley Pain Consultants – Envision Physician Services, Phoenix, AZ, USA,Creighton University School of Medicine, Department of Anesthesiology, Omaha, NE, USA,University of Arizona College of Medicine-Phoenix, Department of Anesthesiology, Phoenix, AZ, USA,Louisiana State University Health Shreveport, Department of Anesthesiology, Shreveport, LA, USA
| | - Alan D. Kaye
- Louisiana State University Health Shreveport, Department of Anesthesiology, Shreveport, LA, USA
| |
Collapse
|
30
|
Yang Z, Wu J, Ye F, Zhu B, Guan W, Huang J, Songyang Z, Liu Y, Chen Y, Du Q, Chen J, Zhang Y, Ke C, Lin Y, Sun B, Zeng J, Chen L, Ren J, Jiang X, Yu M, Di B, Zhong N, Zheng L. Expert consensus-based laboratory testing of SARS-CoV-2. J Thorac Dis 2020; 12:4378-4390. [PMID: 32944351 PMCID: PMC7475603 DOI: 10.21037/jtd-20-1928] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2020] [Accepted: 07/02/2020] [Indexed: 11/06/2022]
Affiliation(s)
- Zifeng Yang
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
| | - Jie Wu
- Guangdong Provincial Center of Disease Prevention and Control, Guangzhou, China
| | - Feng Ye
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
| | - Bing Zhu
- Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
| | - Wenda Guan
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
| | - Jicheng Huang
- Technology Center, Guangzhou Customs, Guangzhou, China
| | - Zhou Songyang
- School of Life Sciences, Sun Yat-sen University; Guangzhou Regenerative Medicine and Health-Guangdong Laboratory (GRMH-GDL), Guangzhou, China
| | - Yong Liu
- Kingmed Virology Diagnostic & Translational Center, Guangzhou Kingmed Center for Clinical Laboratory Co., Ltd., Guangzhou, China
| | - Yi Chen
- Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, China
| | - Qiuling Du
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
- Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, China
| | - Jingxian Chen
- Kingmed Virology Diagnostic & Translational Center, Guangzhou Kingmed Center for Clinical Laboratory Co., Ltd., Guangzhou, China
| | - Yu Zhang
- Guangdong Laboratory Animals Monitoring Institute, Guangdong Provincial Key Laboratory of Laboratory Animals, Guangzhou, China
| | - Changwen Ke
- Guangdong Provincial Center of Disease Prevention and Control, Guangzhou, China
| | - Yongping Lin
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
| | - Baoqing Sun
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
| | - Jun Zeng
- Guangzhou First People’s Hospital, School of Medicine, South China University of Technology, Guangzhou, China
| | - Ling Chen
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
| | - Jiankang Ren
- Kingmed Virology Diagnostic & Translational Center, Guangzhou Kingmed Center for Clinical Laboratory Co., Ltd., Guangzhou, China
| | - Xiwen Jiang
- Da An Gene Co., Ltd of Sun Yat-sen University, Guangzhou, China
| | - Minfei Yu
- Guangzhou Sagene Biotech Co., Ltd., Guangzhou, China
| | - Biao Di
- Guangzhou Center for Disease Control and Prevention, Guangzhou, China
| | - Nanshan Zhong
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
| | - Lei Zheng
- Nanfang Hospital, Southern Medical University, Guangzhou, China
| |
Collapse
|
31
|
Wong GLH, Wong VWS, Thompson A, Jia J, Hou J, Lesmana CRA, Susilo A, Tanaka Y, Chan WK, Gane E, Ong-Go AK, Lim SG, Ahn SH, Yu ML, Piratvisuth T, Chan HLY. Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement. Lancet Gastroenterol Hepatol 2020; 5:776-787. [PMID: 32585136 PMCID: PMC7308747 DOI: 10.1016/s2468-1253(20)30190-4] [Citation(s) in RCA: 62] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/06/2020] [Revised: 05/25/2020] [Accepted: 05/26/2020] [Indexed: 02/06/2023]
Abstract
The COVID-19 pandemic has spread rapidly worldwide. It is common to encounter patients with COVID-19 with abnormal liver function, either in the form of hepatitis, cholestasis, or both. The clinical implications of liver derangement might be variable in different clinical scenarios. With growing evidence of its clinical significance, it would be clinically helpful to provide practice recommendations for various common clinical scenarios of liver derangement during the COVID-19 pandemic. The Asia-Pacific Working Group for Liver Derangement during the COVID-19 Pandemic was formed to systematically review the literature with special focus on the clinical management of patients who have been or who are at risk of developing liver derangement during this pandemic. Clinical scenarios covering the use of pharmacological treatment for COVID-19 in the case of liver derangement, and assessment and management of patients with chronic hepatitis B or hepatitis C, non-alcoholic fatty liver disease, liver cirrhosis, and liver transplantation during the pandemic are discussed.
Collapse
Affiliation(s)
- Grace Lai-Hung Wong
- Department of Medicine and Therapeutics, and Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
| | - Vincent Wai-Sun Wong
- Department of Medicine and Therapeutics, and Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
| | - Alex Thompson
- Department of Gastroenterology, St Vincent's Hospital Melbourne, University of Melbourne, Melbourne, VIC, Australia
| | - Jidong Jia
- Liver Research Centre, Beijing Friendship Hospital, Capital Medical University, Beijing, China
| | - Jinlin Hou
- Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China
| | - Cosmas Rinaldi Adithya Lesmana
- Department of Gastroenterology, Dr Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Jakarta, Indonesia
| | - Adityo Susilo
- Division of Tropical Medicine and Infection, Department of Internal Medicine, Dr Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Jakarta, Indonesia
| | - Yasuhito Tanaka
- Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
| | - Wah-Kheong Chan
- Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - Ed Gane
- New Zealand Liver Transplant Unit, Auckland City Hospital, University of Auckland, Auckland, New Zealand
| | - Arlinking K Ong-Go
- Department of Gastroenterology, Metropolitan Medical Center, Manila, Philippines
| | - Seng-Gee Lim
- Department of Medicine, National University of Singapore, Singapore
| | - Sang Hoon Ahn
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea
| | - Ming-Lung Yu
- Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Taiwan
| | - Teerha Piratvisuth
- Department of Gastroenterology, NKC Institute of Gastroenterology and Hepatology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
| | - Henry Lik-Yuen Chan
- Department of Medicine and Therapeutics, and Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
| |
Collapse
|
32
|
Yang N, Shen Y, Shi C, Ma AHY, Zhang X, Jian X, Wang L, Shi J, Wu C, Li G, Fu Y, Wang K, Lu M, Qian G. In-flight transmission cluster of COVID-19: a retrospective case series. Infect Dis (Lond) 2020; 52:891-901. [PMID: 32735163 DOI: 10.1080/23744235.2020.1800814] [Citation(s) in RCA: 30] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND No data is available about in-flight transmission of SARS-CoV-2. Here, we report an in-flight transmission cluster of COVID-19 and describe the clinical characteristics of these patients. METHODS After a flight, laboratory-confirmed COVID-19 was reported in 12 patients. Ten patients were admitted to the designated hospital. Data was collected from 25th January to 28th February 2020. Clinical information was retrospectively collected. RESULTS All patients were passengers, and none were flight attendants. The median age was 33 years, and 70% were females. None was admitted to intensive care unit, and no patients died up to 28th February. The median incubation period was 3.0 days and time from onset of illness to hospital admission was 2 days. The most common symptom was fever. Two patients were asymptomatic and had normal chest CT scan during hospital stay. On admission, initial RT-PCR was positive in 9 patients, and initial chest CT was positive in half of the patients. The median lung 'total severity score' of chest CT was 6. 'Crazy-paving' pattern, pleural effusion, and ground-glass nodules were seen. CONCLUSION There is potential for COVID-19 transmission in aeroplanes, but the symptoms were mild in our patients. Passengers and attendants must be protected during flights.
Collapse
Affiliation(s)
- Naibin Yang
- Department of Infection and Liver Diseases, Ningbo First Hospital, Ningbo, China.,Department of Infection and Liver Diseases, The first affiliated hospital of Wenzhou Medical University, Wenzhou, China
| | - Yuefei Shen
- Department of Infectious Diseases, Xiaoshan First People's Hospital, Xiaoshan, China
| | - Chunwei Shi
- Department of Infectious Diseases, Xiaoshan First People's Hospital, Xiaoshan, China
| | - Ada Hoi Yan Ma
- Nottingham University Business School, University of Nottingham, Ningbo, China
| | - Xie Zhang
- Department of Pulmon.ary and Critical Care Medicine, Yueqing people's Hospital, Yueqing, China
| | - Xiaomin Jian
- Department of Radiology, Beijing Fuxing Hospital, Affiliated to Capital University of Medical Science, Beijing, China
| | - Liping Wang
- Department of Infection and Liver Diseases, Ningbo First Hospital, Ningbo, China
| | - Jiejun Shi
- Department of Infection and Liver Diseases, Ningbo First Hospital, Ningbo, China
| | - Chunyang Wu
- Department of Infection and Liver Diseases, Ningbo First Hospital, Ningbo, China
| | - Guoxiang Li
- Department of Infection and Liver Diseases, Ningbo First Hospital, Ningbo, China
| | - Yuan Fu
- Department of Radiology, Ningbo First Hospital, Ningbo, China
| | - Keyin Wang
- Department of Infection and Liver Diseases, The First Hospital of Jiaxing City, Jiaxing, China
| | - Mingqin Lu
- Department of Infection and Liver Diseases, The first affiliated hospital of Wenzhou Medical University, Wenzhou, China
| | - Guoqing Qian
- Department of General Internal Medicine, Ningbo First Hospital, Ningbo, China
| |
Collapse
|
33
|
Fernandes LL, Borges L, Pacheco VB, Bernardes A, Ribeiro RR, Jimenez M, Heller D. SARS-CoV-2: A Promising Path in Salivary Diagnosis. Open Dent J 2020. [DOI: 10.2174/1874210602014010343] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023] Open
|
34
|
|
35
|
Rahman MT. Potential benefits of combination of Nigella sativa and Zn supplements to treat COVID-19. J Herb Med 2020; 23:100382. [PMID: 32834942 PMCID: PMC7313527 DOI: 10.1016/j.hermed.2020.100382] [Citation(s) in RCA: 34] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2020] [Revised: 04/23/2020] [Accepted: 06/22/2020] [Indexed: 02/06/2023]
Abstract
The COVID-19 has been declared a pandemic while there is no specific medicine against its causative agent SARS-CoV-2. As an complementary medicine Nigella sativa (black seed) could be considered for its bioactive components such as thymoquinone which was proven to have anti-viral activity. Further benefits to use N. sativa could be augmented by Zn supplement. Notably, Zn has been proven to improve innate and adaptive immunity in course of microbial infection. The effectiveness of the Zn salt supplement can be enhanced with N. sativa as its major bioactive component might work as ionophore to allow Zn2+ to enter pneumocytes and inhibit SARS-CoV-2 replication by stopping its replicase enzyme system.
An effective vaccine to prevent the SARS-CoV-2 causing COVID-19 is yet to be approved. Further there is no drug that is specific to treat COVID-19. A number of antiviral drugs such as Ribavirin, Remdesivir, Lopinavir/ritonavir, Azithromycin and Doxycycline have been recommended or are being used to treat COVID-19 patients. In addition to these drugs, rationale and evidence have been presented to use chloroquine to treat COVID-19, arguably with certain precautions and criticism. In line with the proposed use of chloroquine, Nigella sativa (black seed) could be considered as a natural substitute that contains a number of bioactive components such as thymoquinone, dithymoquinone, thymohydroquinone, and nigellimine. Further benefits to use N. sativa could be augmented by Zn supplement. Notably, Zn has been proven to improve innate and adaptive immunity in the course of any infection, be it by pathogenic virus or bacteria. The effectiveness of the Zn salt supplement could also be enhanced with N. sativa as its major bioactive component might work as ionophore to allow Zn2+ to enter pneumocytes – the target cell for SARSCoV-2. Given those benefits, this review paper describes how N. sativa in combination with Zn could be useful as a complement to COVID-19 treatment.
Collapse
|
36
|
Hermida L, Silva R. COVID-19: An effective vaccine is needed. BIONATURA 2020. [DOI: 10.21931/rb/2020.05.02.1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
A novel coronavirus named SARS-CoV-2 is responsible for the present pneumonia outbreak called COVID-19 that started in early December 2019 in Wuhan City, Hubei province, China. Until March 12, SARS-CoV-2 had caused 80980 infections and 3173 deaths in China, but even worst, it is currently spreading fast in other countries, reaching 45293 infections and 1460 deaths outside China, being the most affected countries Italy, Iran and South Korea
Collapse
Affiliation(s)
- Lisset Hermida
- BioCubaFarma Representative Office, Beijing. China. Address: Room 909, Jingtai Tower, No. 24 Jianguomen Wai Street. Chaoyang District, Beijing, PC 100022
| | - Ricardo Silva
- BioCubaFarma Representative Office, Beijing. China. Address: Room 909, Jingtai Tower, No. 24 Jianguomen Wai Street. Chaoyang District, Beijing, PC 100022
| |
Collapse
|
37
|
Giorgi PD, Villa F, Gallazzi E, Debernardi A, Schirò GR, Crisà FM, Talamonti G, D'Aliberti G. The management of emergency spinal surgery during the COVID-19 pandemic in Italy. Bone Joint J 2020; 102-B:671-676. [PMID: 32323563 DOI: 10.1302/0301-620x.102b6.bjj-2020-0537] [Citation(s) in RCA: 50] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
AIMS The current pandemic caused by COVID-19 is the biggest challenge for national health systems for a century. While most medical resources are allocated to treat COVID-19 patients, several non-COVID-19 medical emergencies still need to be treated, including vertebral fractures and spinal cord compression. The aim of this paper is to report the early experience and an organizational protocol for emergency spinal surgery currently being used in a large metropolitan area by an integrated team of orthopaedic surgeons and neurosurgeons. METHODS An organizational model is presented based on case centralization in hub hospitals and early management of surgical cases to reduce hospital stay. Data from all the patients admitted for emergency spinal surgery from the beginning of the outbreak were prospectively collected and compared to data from patients admitted for the same reason in the same time span in the previous year, and treated by the same integrated team. RESULTS A total of 19 patients (11 males and eight females, with a mean age of 49.9 years (14 to 83)) were admitted either for vertebral fracture or spinal cord compression in a 19-day period, compared to the ten admitted in the previous year. No COVID-19 patients were treated. The mean time between admission and surgery was 1.7 days, significantly lower than 6.8 days the previous year (p < 0.001). CONCLUSION The structural organization and the management protocol we describe allowed us to reduce the time to surgery and ultimately hospital stay, thereby maximizing the already stretched medical resources available. We hope that our early experience can be of value to the medical communities that will soon be in the same emergency situation. Cite this article: Bone Joint J 2020;102-B(6):671-676.
Collapse
Affiliation(s)
- P D Giorgi
- Orthopedics and Traumatology Unit, Emergency and Urgency Department, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy
| | - F Villa
- Neurosurgery Unit, Emergency and Urgency Department, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy
| | - E Gallazzi
- Orthopedics and Traumatology Unit, Emergency and Urgency Department, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy
| | - A Debernardi
- Neurosurgery Unit, Emergency and Urgency Department, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy
| | - G R Schirò
- Orthopedics and Traumatology Unit, Emergency and Urgency Department, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy
| | - F M Crisà
- Neurosurgery Unit, Emergency and Urgency Department, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy.,Università Degli Studi di Milano, Milan, Italy
| | - G Talamonti
- Neurosurgery Unit, Emergency and Urgency Department, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy
| | - G D'Aliberti
- Neurosurgery Unit, Emergency and Urgency Department, A.S.S.T. Grande Ospedale Metropolitano Niguarda, Milan, Italy
| |
Collapse
|
38
|
Salivary diagnostics in COVID-19: Future research implications. J Dent Sci 2020; 15:364-366. [PMID: 32328218 PMCID: PMC7177105 DOI: 10.1016/j.jds.2020.04.006] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2020] [Revised: 04/17/2020] [Indexed: 12/28/2022] Open
|
39
|
Xu R, Cui B, Duan X, Zhang P, Zhou X, Yuan Q. Saliva: potential diagnostic value and transmission of 2019-nCoV. Int J Oral Sci 2020; 12:11. [PMID: 32300101 PMCID: PMC7162686 DOI: 10.1038/s41368-020-0080-z] [Citation(s) in RCA: 212] [Impact Index Per Article: 53.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Revised: 03/31/2020] [Accepted: 04/01/2020] [Indexed: 02/05/2023] Open
Abstract
2019-nCoV epidemic was firstly reported at late December of 2019 and has caused a global outbreak of COVID-19 now. Saliva, a biofluid largely generated from salivary glands in oral cavity, has been reported 2019-nCoV nucleic acid positive. Besides lungs, salivary glands and tongue are possibly another hosts of 2019-nCoV due to expression of ACE2. Close contact or short-range transmission of infectious saliva droplets is a primary mode for 2019-nCoV to disseminate as claimed by WHO, while long-distance saliva aerosol transmission is highly environment dependent within indoor space with aerosol-generating procedures such as dental practice. So far, no direct evidence has been found that 2019-nCoV is vital in air flow for long time. Therefore, to prevent formation of infectious saliva droplets, to thoroughly disinfect indoor air and to block acquisition of saliva droplets could slow down 2019-nCoV dissemination. This review summarizes diagnostic value of saliva for 2019-nCoV, possibly direct invasion into oral tissues, and close contact transmission of 2019-nCoV by saliva droplets, expecting to contribute to 2019-nCoV epidemic control.
Collapse
Affiliation(s)
- Ruoshi Xu
- State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - Bomiao Cui
- State Key Laboratory of Oral Diseases & Human Saliva Laboratory & National Clinical Research Center for Oral Diseases & West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - Xiaobo Duan
- State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - Ping Zhang
- State Key Laboratory of Oral Diseases & Human Saliva Laboratory & National Clinical Research Center for Oral Diseases & West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - Xuedong Zhou
- State Key Laboratory of Oral Diseases & Human Saliva Laboratory & National Clinical Research Center for Oral Diseases & West China Hospital of Stomatology, Sichuan University, Chengdu, China
| | - Quan Yuan
- State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & West China Hospital of Stomatology, Sichuan University, Chengdu, China
| |
Collapse
|